Country - Germany
Summary - Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Deadline - Apr 30, 2026
MT reference number - 82043459
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 82043459
Document Type - Tender Notices
Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medicinal products with the active ingredient Rivaroxaban (ATC: B01AF01 - with a potenc y of 2.5 mg per divided oral dosage form) within the framework of a so-called "open-house" model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the above-mentioned active ingredients or medicines. Inter
Mt Ref Id - 82043459
Deadline - Apr 30, 2026
Similar Tenders :
Healthcare and Medicine